INS and type 1 diabetes mellitus: Even the use of the latest modern therapeutic approaches (e.g., ultrafast-acting insulin analogues, insulin pumps, smart algorithms, hybrid closed-loop systems) cannot match the precise physiological metabolic regulation in those without T1D [23,24].